Storys zum Thema Medizin, Gesundheit
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
NUCLEAI AND DEBIOPHARM LAUNCH RESEARCH COLLABORATION UTILIZING NUCLEAI’S AI-POWERED BIOMARKER PLATFORM
Tel Aviv, Israel / Lausanne, Switzerland (ots) - Nucleai (www.Nucleaimd.com), a global provider in pathology-based biomarker discovery, and Debiopharm (www.debiopharm.com), a Swiss-based biopharmaceutical company specializing in drug development, announced that they have entered into a long-term collaboration to ...
mehrHovione Launches ASD-HIPROS the Most Advanced Screening Service for Optimal Spray Dried Dispersions Formulation
Lisbon, Portugal (ots/PRNewswire) - Hovione, the leader in Pharmaceutical Spray Drying, today announced the launch of ASD-HIPROS, a proprietary screening service for spray dried dispersions. This platform is the most advanced and most accurate tool to identify optimal and commercially viable Amorphous Solid ...
mehrAVECTAS Appoints Daniel Castro as Chief Business Officer
Dublin (ots/PRNewswire) - - Newly created role of Chief Business Officer to drive commercialization strategy including partnering SOLUPORE®, Avectas' non-viral cell engineering technology - Daniel Castro brings 25 years of healthcare and pharmaceutical industry experience, with a focus on licensing and deal-making - Based in Boston, MA, at the heart of a major global biotech cluster Avectas, a cell engineering company ...
mehrForaCare Suisse AG releases Rapid COVID-19 Antigen Test / Test Results in 15 Minutes, No Laboratory Processing Required, Highly Accurate & Reliable Results
ST. GALLEN, Switzerland (ots) - ForaCare Suisse AG announced the release of its antigen test, FORA COVID-19 Antigen Rapid Test, that provides fast, accurate and easy-to-interpret test results. The test can be administered by trained professionals and doesn’t rely on laboratory-processing. Approved by Swissmedic, ...
mehrServier to Acquire Agios Pharmaceuticals' Oncology Business
Paris and Boston (ots/PRNewswire) - - Transaction includes commercial, clinical and research-stage oncology portfolio and employees for up to $2 billion plus royalties - Includes Agios' marketed medicine TIBSOVO® and a strong oncology pipeline of Phase 3 and early-stage assets - Acquisition in-line with Servier's strategic ambition to become a recognized and innovative player in oncology, supported by unique drug ...
mehrTianjin Jinyun New Media Group
Tianjin Jinyun New Media Group presents a video on Scientific Traditional Chinese Medicine
Tianjin, China (ots/PRNewswire) - Traditional Chinese Medicine has played an important role in the worldwide fight against COVID-19. This short video introduces TCM's cultural inheritance, anti-epidemic achievements, its scientific and technological innovation and its efforts to safeguard human health and protect people's lives. Contact: Yan Zheng Tel: 0086-18622969907 ...
mehrRoche teams up with Diabeloop to advance the management of insulin pump therapy
Basel (ots/PRNewswire) - - The partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes1. - By partnering with Diabeloop, Roche steps into the field of automated insulin delivery (AID) representing a milestone in Roche's strategy of integrated Personalised Diabetes Management ...
mehrRoche teams up with Diabeloop to advance the management of insulin pump therapy
Basel (ots) - - The partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes(1). - By partnering with Diabeloop, Roche steps into the field of automated insulin delivery (AID) representing a milestone in Roche's strategy of integrated Personalised Diabetes Management (iPDM). Roche ...
mehrEANS-News: AGRANA: Weekly rapid coronavirus tests for employees prove their worth
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Frankfurt, Berlin, Stuttgart, Wien language: ...
mehrNovaliq Announces First Patient Randomized in the Phase 3 trial ESSENCE-2 of CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease
Heidelberg, Germany (ots/PRNewswire) - - ESSENCE-2 is the second registration trial to complete the clinical development of CyclASol® as agreed with U.S. Food and Drug Administration (FDA) - Designed to replicate efficacy demonstrated in previous phase 2/3 ESSENCE-1 trial - Topline data expected in 2nd half 2021 ...
mehrAbcam reveals new cell engineering facility in Bay Area
Cambridge, England (ots/PRNewswire) - - State-of-the-art site will enable rapid delivery of engineered cell lines - Powering ready-to-use edited cell-line portfolio expansion - Enable comprehensive customization for research, diagnostic and therapeutic development Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the opening of a new 16,000 sq ft purpose-fitted facility ...
mehrSIFI Press & Communication Office
SIFI appoints Jelle Kleijn as Global Head of Acanthamoeba Keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening parasitic eye infection
Catania, Italy (ots/PRNewswire) - Given urgency to treat, SIFI has established a dedicated cross-functional team to accelerate the launch of polihexanide monotherapy in Europe and the United States. SIFI, a leading ophthalmic company, is pleased to announce the recent appointment of Jelle Kleijn, PhD, as Global Head ...
mehrBD (Becton, Dickinson and Company)
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years
Franklin Lakes, N.j. (ots/PRNewswire) - - Investment includes new manufacturing facility in Europe BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and ...
mehrNorgine B.V. Announces New European Healthcare Subsidiary To Strengthen Its Consumer Healthcare Portfolio
Amsterdam, The Netherlands (ots/PRNewswire) - Norgine B.V. ("Norgine"), today announced the establishment of a wholly-owned subsidiary, Norgine Healthcare B.V. ("Norgine Healthcare"), which will be dedicated to consumer healthcare. To view the Multimedia News Release, please click: ...
mehrEuropean Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations
Darmstadt, Germany (ots/PRNewswire) - Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial ...
mehrHelsana Drug Report: Spitex patients exposed to significant medication risks
Zurich (ots) - In 2019, medication costs in Switzerland totalled approximately CHF 7.6 billion. The front runners remained cancer and immune system drugs, followed by nervous system medications and metabolic preparations. The use of biosimilars (generic preparations) offers significant savings potential that unfortunately remains almost completely unexploited. In an ...
mehrFresenius Kabi Deutschland GmbH
Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition
BAD HOMBURG (ots) - Evidence indicates that omega-3 (?-3) fatty acid containing parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients,1 underlining its role in today's hospitals and clinics. To support continuous health care professional (HCP) education on omega-3 fatty ...
mehrZentiva Continues Its Planet-Z Program For A Healthier Planet By Planting 4,500 Trees In Portugal
Prague (ots/PRNewswire) - Zentiva Group will plant 4,500 new trees as part of its PlanetZ program which aims to make a continuous and positive contribution to our environment. Zentiva is collaborating with the Associação Nacional de Empresas Florestais, Agrícolas e do Ambiente (ANEFA), an NGO in Portugal, to make it happen. The trees will be planted in Baldio do ...
mehrGH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress
Dublin (ots/PRNewswire) - GH Research Limited ("GH Research" or "the Company") today announced the successful completion of a Phase 1 clinical study with GH001 in healthy volunteers. The Company is currently recruiting for a Phase 1/2 clinical study with GH001 in patients with Treatment-Resistant Depression. GH ...
mehrGlobal leaders welcome the Sanitation and Hygiene Fund as key to increasing investment
Geneva (ots/PRNewswire) - The Sanitation and Hygiene Fund will be critical to dramatically scale up investments to reach everyone with sanitation services, United Nations Deputy Secretary-General has said as the new financial mechanism to drive billions of dollars into the sanitation sector was launched today. Speaking at the launch of the new Sanitation and Hygiene ...
mehr- 3
Global leaders welcome the Sanitation and Hygiene Fund as key to increasing investment
mehr Bram Goorden joins SOPHiA GENETICS as Chief Commercial Officer and Head of North America
Boston and Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Bram Goorden joined its Executive team, holding the dual role of Chief Commercial Officer and Head of North America. Goorden comes to SOPHiA from Foundation Medicine Inc. (Cambridge, MA) where he held the role of VP of International Business and ...
mehrStudy shows dramatic rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown earlier this year
mehrFORA® 6 Blood Glucose Monitors Help Diabetic Patients Monitor COVID-19 Risks
mehr- 2
The Sanitation and Hygiene Fund to be launched on 17 November
mehr Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
mehrMerck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up to EUR 605 million in development ...
mehrOrbusNeich® Medical and P+F Products & Features® announce new partnership
Hong Kong (ots/PRNewswire) - Introducing a new portfolio of heart valve products aiming to restore health and extend life OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive heart valve products in the Asia Pacific region, including China, Japan, Taiwan, ...
mehrMagnostics is Co-Developing and Launching a Viral RNA Extraction Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR
Dublin (ots/PRNewswire) - Magnostics is leading a consortium of University and National Researchers to develop and launch Viral RNA Extraction Kits for detection of COVID-19. A team of scientist from Saint Vincent University Hospital, National Virus Reference Laboratory, University College Dublin, and Magnostics ...
mehr